Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High genetic diversity of porcine rotavirus A, B, and C in Hungary with putative novel VP4 genotypes.

BMC veterinary research·2026
Same author

AI-Based Predictive Modelling and Alert Framework for Mortality Risk and Cost-Benefit Analysis in Rabbit Production.

Veterinary sciences·2026
Same author

A New Family-Based Approach for Detecting Allele-Specific Expression and for Mapping Possible eQTLs.

Animals : an open access journal from MDPI·2025
Same author

Whole-Genome Sequencing-Based Population Genetic Analysis of Wild and Domestic Rabbit Breeds.

Animals : an open access journal from MDPI·2025
Same author

Pedigree-Based Description of Danubia Alba Rabbit Breed Lines.

Animals : an open access journal from MDPI·2024
Same author

Genomic Analysis of <i>Staphylococcus aureus</i> Strains Originating from Hungarian Rabbit Farms Reinforce the Clonal Origin of Various Virulence Types.

Animals : an open access journal from MDPI·2020

Related Experiment Video

Updated: Jun 19, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
09:24

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Published on: August 22, 2017

Rietveld refinement in the routine quantitative analysis of famotidine polymorphs.

Zoltán Német1, István Sajó, Adám Demeter

  • 1Drug Polymorphism Research Division, Gedeon Richter Plc., P.O. Box 27, H-1475 Budapest, Hungary. z.nemet@richter.hu

Journal of Pharmaceutical and Biomedical Analysis
|October 13, 2009
PubMed
Summary

A new X-ray powder diffraction method accurately quantifies famotidine polymorphic forms. This technique offers improved reliability over Raman spectroscopy for pharmaceutical analysis.

More Related Videos

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Related Experiment Videos

Last Updated: Jun 19, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
09:24

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Published on: August 22, 2017

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
07:36

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

Area of Science:

  • Analytical Chemistry
  • Materials Science
  • Pharmaceutical Analysis

Background:

  • Famotidine exists in multiple polymorphic forms, impacting drug efficacy and stability.
  • Accurate quantification of these forms is crucial for pharmaceutical quality control.
  • Existing methods like Raman spectroscopy have limitations in certain applications.

Purpose of the Study:

  • To develop and validate a precise X-ray powder diffraction (XRPD) method for quantitative determination of famotidine polymorphic forms.
  • To compare the performance of the developed XRPD method with the established Raman spectroscopy method.
  • To optimize XRPD parameters for routine, high-throughput analysis.

Main Methods:

  • Development of an X-ray powder diffraction method utilizing focused beam transmission geometry.
  • Implementation of a straightforward transmission foil sample preparation technique.
  • Application of Rietveld refinement for quantitative analysis of famotidine polymorphic forms in binary mixtures.

Main Results:

  • The developed XRPD method demonstrated high accuracy, precision, and reliability for quantitative determination of famotidine polymorphic forms.
  • The XRPD method slightly outperformed the previously established Raman method in terms of accuracy and reliability.
  • Focused beam transmission geometry effectively minimized preferred orientation effects.
  • Transmission foil sample preparation enabled efficient, high-throughput measurements.

Conclusions:

  • The optimized XRPD method provides a robust and reliable approach for quantifying famotidine polymorphic forms.
  • This method offers advantages over existing techniques, particularly in handling preferred orientation and enabling high-throughput analysis.
  • The developed XRPD method is suitable for routine application in pharmaceutical quality control.